肝硬化药物管理中的现状和未来方向
Chalermrat Bunchorntavakul1, K Rajender Reddy2
1Division of Gastroenterology and Hepatology, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, 2 Phayathai Road, Ratchathewi, Bangkok 10400, Thailand.
Clinics in liver disease
|October 18, 2025
概括
非选择性β-阻断剂是有效的预防肝脏衰减. 然而,对他类药物和利法西明等替代药物治疗的研究仍在进行中,需要进一步的临床试验以获得更广泛的应用.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 肝脏衰竭带来很大的风险,需要有效的药理干预措施.
- 目前,非选择性β抑制剂是减轻这种风险的主要治疗方法.
- 持续的治疗缺口凸显了对新或补充治疗策略的需求.
研究的目的:
- 审查新兴的药物疗法,以预防肝脏衰竭.
- 评估除非选择性β抑制剂之外的替代治疗的潜力.
- 确定需要进一步临床研究的领域.
主要方法:
- 最近临床试验和研究的文献综述.
- 对肝脏不补偿症的拟议药理疗法的分析.
- 评估支持替代疗法的证据.
主要成果:
- 非选择性β抑制剂被认为是有效的.
- 几种替代药物疗法显示出有前途,包括他类药物,利法西明,白蛋白,抗凝剂,血管激素受体阻断剂,颗粒细胞殖民地刺激因子和便微生物移植.
- 目前的数据主要基于有限的临床试验.
结论:
- 虽然有希望,但替代药物疗法需要进一步严格调查,特别是随机对照试验.
- 在某些情况下,证据不足以建议采用常规临床实践.
- 持续的研究对于扩大肝脏不补偿的治疗选择至关重要.
更多相关视频
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Inflammatory Bowel Disease IV: Pharmacological Management
496
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
496
Esophageal Varices-II: Clinical Features and Management
366
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
366
Pleural Effusion II: Symptoms and Management
647
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
647
Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311


